ZA976592B - Formulation - Google Patents

Formulation

Info

Publication number
ZA976592B
ZA976592B ZA976592A ZA976592A ZA976592B ZA 976592 B ZA976592 B ZA 976592B ZA 976592 A ZA976592 A ZA 976592A ZA 976592 A ZA976592 A ZA 976592A ZA 976592 B ZA976592 B ZA 976592B
Authority
ZA
South Africa
Prior art keywords
formulation
Prior art date
Application number
ZA976592A
Other languages
English (en)
Inventor
Dirk Marinus Johanne Van-Schie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA976592B publication Critical patent/ZA976592B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA976592A 1996-07-25 1997-07-24 Formulation ZA976592B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation

Publications (1)

Publication Number Publication Date
ZA976592B true ZA976592B (en) 1999-03-04

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA976592A ZA976592B (en) 1996-07-25 1997-07-24 Formulation

Country Status (24)

Country Link
EP (1) EP0918521B1 (de)
JP (1) JP2000515868A (de)
KR (1) KR20000029523A (de)
CN (1) CN1226163A (de)
AR (1) AR007983A1 (de)
AT (1) ATE224711T1 (de)
BR (1) BR9710546A (de)
CA (1) CA2261233A1 (de)
CO (1) CO5031290A1 (de)
CZ (1) CZ22799A3 (de)
DE (1) DE69715878T2 (de)
DK (1) DK0918521T3 (de)
ES (1) ES2184121T3 (de)
GB (1) GB9615628D0 (de)
HK (1) HK1021314A1 (de)
IL (1) IL128095A (de)
NO (1) NO990283L (de)
NZ (1) NZ333704A (de)
PL (1) PL331283A1 (de)
PT (1) PT918521E (de)
TR (1) TR199900141T2 (de)
TW (1) TW426514B (de)
WO (1) WO1998004258A1 (de)
ZA (1) ZA976592B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
AU2002211067A1 (en) * 2000-09-27 2002-04-08 Dsm N.V. Process for the carbonylation of a conjugated diene
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
JP7293560B2 (ja) 2017-12-29 2023-06-20 グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド 芳香族ビニルまたは芳香族エチル系誘導体、その製造方法、中間体、薬物組成物および使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392803B1 (de) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Chemische Verbindungen
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
AR007983A1 (es) 1999-11-24
NO990283L (no) 1999-03-19
KR20000029523A (ko) 2000-05-25
PT918521E (pt) 2003-02-28
IL128095A (en) 2002-07-25
DK0918521T3 (da) 2003-02-03
TR199900141T2 (xx) 1999-03-22
JP2000515868A (ja) 2000-11-28
BR9710546A (pt) 1999-08-17
CZ22799A3 (cs) 1999-06-16
NZ333704A (en) 2000-06-23
IL128095A0 (en) 1999-11-30
GB9615628D0 (en) 1996-09-04
CO5031290A1 (es) 2001-04-27
CA2261233A1 (en) 1998-02-05
HK1021314A1 (en) 2000-06-09
CN1226163A (zh) 1999-08-18
ATE224711T1 (de) 2002-10-15
TW426514B (en) 2001-03-21
WO1998004258A1 (en) 1998-02-05
DE69715878D1 (de) 2002-10-31
EP0918521B1 (de) 2002-09-25
AU721101B2 (en) 2000-06-22
AU3768497A (en) 1998-02-20
DE69715878T2 (de) 2003-05-22
ES2184121T3 (es) 2003-04-01
EP0918521A1 (de) 1999-06-02
NO990283D0 (no) 1999-01-22
PL331283A1 (en) 1999-07-05

Similar Documents

Publication Publication Date Title
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
ZA95776B (en) Novel formulation
ZA9710601B (en) Novel formulation
ZA9811461B (en) New formulation
ZA985669B (en) New formulation
GB9724544D0 (en) Novel Formulation
ZA9810773B (en) Revitalisation formulation
GB9706957D0 (en) Formulation
GB9621990D0 (en) Use
ZA976592B (en) Formulation
AU131132S (en) Handleset
GB9611192D0 (en) Use
AU131198S (en) Handleset
GB9404989D0 (en) Lipomimetric formulation
HU9602732D0 (en) Lanperisone formulation
AU131131S (en) Handleset
AU131199S (en) Handleset
GB9721807D0 (en) Formulation
GB9725275D0 (en) Formulation
GB9412641D0 (en) Formulation
ZA952272B (en) Formulation
GB9412642D0 (en) Formulation
GB9423416D0 (en) Formulation
GB9416500D0 (en) Formulation
GB9624115D0 (en) Formulations